U.S. Market Projected to Reach USD 1.19 Billion by 2035, While Europe Advances Toward USD 0.94 Billion Amid Pharmaceutical Growth and REACH Compliance Requirements
U.S. Market Projected to Reach USD 1.19 Billion by 2035, While Europe Advances Toward USD 0.94 Billion Amid Pharmaceutical Growth and REACH Compliance Requirements